How Will the Market React to Beyondspring Inc (BYSI) Stock Getting a Bullish Rating

Overall market sentiment has been high on Beyondspring Inc (BYSI) stock lately. BYSI receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Beyondspring Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on BYSI!

See Full BYSI Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With BYSI Stock Today?

Beyondspring Inc (BYSI) stock has risen 2.8% while the S&P 500 has fallen -0.81% as of 1:31 PM on Friday, Oct 13. BYSI is up $0.03 from the previous closing price of $1.07 on volume of 281,700 shares. Over the past year the S&P 500 is up 20.62% while BYSI is up 17.02%. BYSI lost -$0.85 per share in the over the last 12 months.

More About Beyondspring Inc

BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China. Click Here to get the full Stock Report for Beyondspring Inc stock.